Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Artelo Biosciences, Inc. (ARTL) had Return on Investments of -48.57% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.43M |
|
-- |
|
-- |
|
$2.50M |
|
$-2.50M |
|
$0.08M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.50M |
|
$-2.48M |
|
2.71M |
|
2.71M |
|
$-0.89 |
|
$-0.89 |
|
| Balance Sheet Financials | |
$4.37M |
|
-- |
|
$2.09M |
|
$6.46M |
|
$1.46M |
|
-- |
|
$0.01M |
|
$1.46M |
|
$5.00M |
|
$2.96M |
|
$5.00M |
|
4.19M |
|
| Cash Flow Statement Financials | |
$-6.22M |
|
-- |
|
$9.80M |
|
$0.60M |
|
$4.20M |
|
$3.60M |
|
$0.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-48.57% |
|
-82.05% |
|
-37.58% |
|
|
Return on Investments |
-48.57% |
$1.19 |
|
$-2.29 |
|
$-2.29 |
|